Skip to main content

Diazoxide use while Breastfeeding

Medically reviewed by Last updated on Jan 3, 2024.

Drugs containing Diazoxide: Proglycem, Hyperstat, Hyperstat IV

Diazoxide Levels and Effects while Breastfeeding

Summary of Use during Lactation

Limited information indicates that maternal doses of oral diazoxide up to 175 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants. If oral diazoxide is required by the mother, it is not a reason to discontinue breastfeeding. Monitoring of the infant’s blood glucose may be advisable, especially during the newborn period.

Drug Levels

Maternal Levels. A woman with nesidioblastosis hypoglycemia had been on diazoxide for 30 years since the age of 4 months. Diazoxide was stopped during her pregnancies, but reinstated at week 25 of her second pregnancy in a dose of 50 mg three times daily and later the dosage schedule was 50 mg, 50 mg and 75 mg after her third meal of the day. Milk samples were taken 6 times between day 3 and day 8 postpartum. The highest concentrations in milk were 2.4 mg/L at 3 hours after a 50 mg dose and 3.1 mg/L at 3.4 hours after a 75 mg dose. The lowest measured level was 0.7 mg/L at 9 hours after a 75 mg dose.[1]

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

One infant was partially breastfed (10 to 50% initially, then 80% at 1 month of age) by a mother taking diazoxide orally in dosages of 150 to 175 mg daily for hypoglycemia. At 30 days of age, the infant was developing normally and had experienced no episodes of hypo- or hyperglycemia.[1]

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.


Saito J, Kawasaki H, Adachi N, et al. Diazoxide during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum: A case report. Gynecol Endocrinol. 2022;38:528–30. [PubMed: 35403531]

Substance Identification

Substance Name


CAS Registry Number


Drug Class

Breast Feeding


Milk, Human

Antihypertensive Agents

Vasodilator Agents

Blood Glucose

Glycemic Control

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.